Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Harrow Health Inc.
Headquarters:
Nashville, TN, United States
Website:
https://www.harrowinc.com/
Year Founded:
2018
Status:
Public
Industry Sector:
HealthTechnology
CEO:
Mark L. Baum
Number Of Employees:
382
Enterprise Value:
$1,377,307,455
PE Ratio:
-47.84
Exchange/Ticker 1:
NASDAQ:HROW
Exchange/Ticker 2:
N/A
Latest Market Cap:
$865,403,840
BioCentury
|
Nov 26, 2024
Politics, Policy & Law
Marty Makary’s turn in the spotlight
Trump’s FDA commissioner pick has complex, controversial history
Read More
BioCentury
|
Nov 23, 2024
Politics, Policy & Law
Trump 2.0 presents opportunities, threats
A clear understanding of threats and opportunities will be essential as the biopharma industry steps into the second Trump administration
Read More
BioCentury
|
Aug 3, 2023
Data Byte
July follow-on financings: argenx raised majority of month’s $2.1B total
Ten biopharmas raised a combined $2.1B in July, of which argenx was responsible for nearly $1.3B
Read More
BioCentury
|
May 18, 2018
Financial News
Imprimis spinout Surface raises $20M series A
Read More
BioCentury
|
May 15, 2018
Financial News
Imprimis spinout Surface raises $20M series A
Read More
BioCentury
|
Jul 28, 2017
Financial News
Imprimis secures $16M loan facility from SWK Holdings
Read More
BioCentury
|
Mar 30, 2017
Financial News
Imprimis completes registered public offering
Read More
BioCentury
|
Dec 22, 2016
Financial News
Imprimis completes private placement
Read More
Items per page:
10
1 - 8 of 8